Down 83%! This FTSE 250 firm could now be a stock market takeover target
Image source: Getty Images It’s been a torrid few years for shareholders of Oxford Nanopore Technologies (LSE: ONT). Since the biotech company listed on the UK stock market in late 2021, its share price has crashed by more than 80%. This is sad to see as the FTSE 250 firm’s founders had ambitions to build a homegrown British giant in the healthcare space. The sharp fall means Oxford Nanopore’s market cap now stands at just under £1bn — hardly the status of a giant! Acquisition target For those unfamiliar, Oxford...